Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 947 results for "first pharma"

Intas Pharma launches first etanercept biosimilar

Intas Pharmaceuticals has launched INTACEPT, the first biosimilar to Amgen’s Enbrel (etanercept). INTACEPT has been launched in two strengths, 25mg in 0.5 ml and 50 mg in 1.0 ml preservative free solution, in easy to use pre-filled syringes. Times of India, 5 hours ago

76 images for first pharma

Pharmafocus, 2 days ago
Business Standard, 1 week ago
NewsReality.com, 2 days ago
Business Standard, 2 days ago
Business Standard, 2 days ago
NewsReality.com, 2 days ago
NewsReality.com, 2 days ago
NewsReality.com, 2 days ago
NewsReality.com, 2 days ago
Business Standard, 2 days ago
Outlook

Making A Turbinator

What does Shanghvi’s first foray in a non-pharma firm mean? business: Dilip shanghvi Here, Finally, Comes The Sun Dilip Shanghvi’s ascent to Mt Richest was done with silent focus Gauri Kamath What does one make of Dilip Sha­nghvi’s investment in ...
 Outlook2 weeks ago Need to regain trust of regulators post Ranbaxy deal: Dilip Shanghvi, Sun Pharma  Economic Times1 day ago Dilip Shanghvi's success: From a start-up to India's largest drug maker  Rediff.com2 weeks ago Dilip Shanghvi bets big on other businesses  Rediff.com1 month ago
Bio Spectrum Asia

Bukwang Pharm appoints Korea's first female CEO

Singapore: Korean-based Bukwang Pharm announced the appointment of Ms Yu Hee-won as the co-president and CEO of Bukwang Pharm. The move marks the appointment of Korea's first female CEO for the pharmaceutical industry. An official from the ...
 Bio Spectrum Asia4 days ago

Natco Pharma up 4%, launches hepatitis C drug in Nepal

Shares of Natco Pharma gained 4.4 percent intraday on Monday on launching the first generic version of sofosbuvir in Nepal.
 Money Control2 weeks ago Natco and Hetero to launch Hep-C drug  The Financial Chronicle2 weeks ago Natco wins India regulator nod for Sovaldi generic  DNA2 weeks ago Natco Pharma launches HEPCINAT in Nepal  Business Standard2 weeks ago

Sun Pharma: Multiple triggers point to a healthy outlook

Upsides from research pipeline of SPARC and first approval from Halol facility are positives Ram Prasad Sahu March 4, 2015 Last Updated at 21:35 IST Related News Sun Pharma: Multiple triggers point to a healthy outlook Sun Pharma and Sun Pharma Advanced ...
 Business Standard3 weeks ago

Sensex scales mount 30K in a first; Sun Pharma surges 8%

NEW DELHI: The S BSE Sensex pared some gains after rallying as much as 434 points in trade on Wednesday to hit its fresh record highs above its psychological level of 30,000 for the first time ever. Tracking the momentum, the 50-share Nifty index also pared ...
 Economic Times3 weeks ago Sensex, Nifty hit fresh peaks on robust fund inflows  Deccan Herald2 months ago Markets at new highs on capital inflows, pre-budget optimism  Jagran Post2 months ago

Sensex breaches 29,000 for first time;metals,pharma lead

According to analysts, the market looks overbought at current levels and traders should be cautious as some profit booking may be seen in the near-term. At 09:20 a.m.; the 30-share index was at 28,992.31, up 103.45 points or 0.36 per cent. It touched an ...
 Economic Times2 months ago

Ajanta Pharma: First Launch Winner

From Pinkoo gripe water to branded formulations, Ajanta Pharma has come a long way to become.a specialist in cardio-vasculars By Mohammed Ekramul Haque | Jan 1, 2015 Remember the TV advertisements of Pinkoo gripe water? Launched in 1979, Pinkoo was Ajanta ...
 Value Research Online2 months ago
Pharma Letter

Frontier Pharma: Pain Pipeline 2015 - Identifying and Commercializing First-in-Class Innovation

Research and Markets (http://www.researchandmarkets.com/research/ztgl4v/frontier_pharma) has announced the addition of the "Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation" report to their offering. The active pain ...
 Individual.com4 days ago Antibiotics has an extensive pipeline but first-in-class innovation is low  Pharma Letter2 days ago Research and Markets Adds Report: Frontier Pharma: Alzheimer's Disease  Individual.com1 day ago Frontier Pharma: Liver Cancer Pipeline 2015 - Identifying and Commercializing First-in-Class Innovation  Individual.com4 days ago
[x]  

INNATE PHARMA : DSMB RECOMMENDS CONTINUATION OF EFFIKIR TRIAL WITH TWO ARMS

Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer and inflammatory diseases, today announces that the Data and Safety Monitoring Board ...
 Individual.com1 day ago REG-INNATE PHARMA : DSMB RECOMMENDS CONTINUATION OF EFFIKIR TRIAL WITH TWO ARMS  Reuters1 day ago Innate Pharma: DSMB Recommends Continuation Of EffiKIR Trial With Two Arms  FirstWord Pharma1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less